How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process

Food Drug Law J. 2003;58(1):103-27.

Author

Barbara Ann Binzak¹

Affiliation

¹ Buchanan Ingersoll P.C., Washington, D.C., USA.

PMID: 12739592

No abstract available

MeSH terms

Clinical Trials as Topic / legislation & jurisprudence*
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Clinical Trials, Phase IV as Topic
Drug Approval / legislation & jurisprudence*
Drug Industry / economics
Pharmacogenetics / legislation & jurisprudence*
United States
United States Food and Drug Administration